European Union Approves Amgevita for Crohn’s Disease and Ulcerative Colitis
News
The European Union has approved Amgen‘s Amgevita, a biosimilar to Humira (adalimumab), as a treatment for inflammatory bowel diseases (IBDs) such as Crohn’s and ulcerative colitis. The European Commission decision applies ... Read more